Showing results (241-250 of 371) with videos related to

Sort By:
Pageof 38
Frontiers in Psychiatry|July 31, 2023
Psychiatrists' attitudes towards functional neurological disorders: results from a national surveyAngela Marotta, Antonio Lasalvia, Mirta Fiorio, et al.
European Journal of Psychotraumatology|October 14, 2022
Trajectories of psychosocial symptoms and wellbeing in asylum seekers and refugees exposed to traumatic events and resettled in Western Europe, Turkey, and UgandaMarianna Purgato, Federico Tedeschi, Giulia Turrini, et al.
Molecular Psychiatry|November 13, 2023
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disordersMarco Solmi, Samuele Cortese, Giovanni Vita, et al.
Journal of Clinical Psychopharmacology|April 22, 2011
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trialCorrado Barbui, Simone Accordini, Michela Nosè, et al.
The Journal of Clinical Psychiatry|November 26, 2008
Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysisAndrea Cipriani, Toshiaki A Furukawa, John R Geddes, et al.
BMC Medicine|November 28, 2025
Efficacy and safety of esketamine for "treatment resistant depression": registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trialsFlorian Naudet, Claude Pellen, Liviu A Fodor, et al.
BMC Psychiatry|June 25, 2020
Correction to: Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illnessJayati Das-Munshi, Maya Semrau, Corrado Barbui, et al.
BMC Psychiatry|May 16, 2020
Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illnessJayati Das-Munshi, Maya Semrau, Corrado Barbui, et al.
International Clinical Psychopharmacology|August 16, 2008
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?Michela Nosè, Michele Tansella, Graham Thornicroft, et al.
BMJ Mental Health|March 14, 2025
Effectiveness of Self-Help Plus in its digital version in reducing anxiety and post-traumatic symptomatology among nursing home workers during the COVID-19 pandemic: secondary analysis of randomised controlled trial dataMarianna Purgato, Federico Tedeschi, Marianna Riello, et al.
Pageof 38